Advanced search
Publication Cover
Clinical Ophthalmology Volume 3, 2009 - Issue
Submit an article Journal homepage
173
Views
39
CrossRef citations to date
0
Altmetric
Original Research

Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%

Seenu M Hariprasad1 Department of Ophthalmology and Visual Sciences, Vitreoretinal ServiceCorrespondence[email protected]
,
Levent Akduman2 Vitreoretinal Service, Saint Louis University Eye Institute, Saint Louis, MO, USA
,
Joseph A Clever2 Vitreoretinal Service, Saint Louis University Eye Institute, Saint Louis, MO, USA
,
Michael Ober3 Vitreoretinal Service, Henry Ford Health Systems, West Bloomfield, MI, USA;4 Retinal Consultants of Michigan, Southfield, MI, USA
,
Franco M Recchia5 Vitreoretinal Service, Vanderbilt Eye Institute, Nashville, TN, USA
&
William F Mieler1 Department of Ophthalmology and Visual Sciences, Vitreoretinal Service;6 Department of Ophthalmology and Visual Sciences, University of Chicago, Chicago, IL, USA
Pages 147-154 | Published online: 20 Jan 2009

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Aslıhan Yılmaz Çebi & Mustafa Hepokur. (2023) OCT imaging of macular cysts and treatment response with nepafenac in mucopolysaccharidosis type 1. Ophthalmic Genetics 44:3, pages 273-275.
Read now
Unnikrishnan Nair, Ashwin Mohan & Manoj Soman. (2020) Plume Sign in the Deturgescence of Macular Cysts – A Novel OCT Finding. Clinical Ophthalmology 14, pages 759-765.
Read now
Ricardo Alexandre Stock, Daiane Karen Galvan, Rafael Godoy & Elcio Luiz Bonamigo. (2018) Comparison of macular thickness by optical coherence tomography measurements after uneventful phacoemulsification using ketorolac tromethamine, nepafenac, vs a control group, preoperatively and postoperatively. Clinical Ophthalmology 12, pages 607-611.
Read now
Harry Petrushkin, Duncan Rogers & Carlos Pavesio. (2018) The Use of Topical Non-steroidal Anti-inflammatory Drugs for Uveitic Cystoid Macular Edema. Ocular Immunology and Inflammation 26:5, pages 795-797.
Read now
Ramesh Jha, Vismapratap Sur, Arnab Bhattacharjee, Tanushri Ghosh, Vinod Kumar, Aditya Konar & Sarbani Hazra. (2018) Intracameral Use of Nepafenac: Safety and Efficacy Study. Current Eye Research 43:5, pages 630-638.
Read now
Bora Yüksel, Umut Duygu Uzunel, Süleyman Gökhan Kerci, Levent Sağban, Tuncay Küsbeci & Tümay Örsel. (2017) Comparison of Subtenon Triamcinolone Acetonide Injection with Topical Nepafenac for the Treatment of Pseudophakic Cystoid Macular Edema. Ocular Immunology and Inflammation 25:4, pages 513-519.
Read now
Khawla Abu Samra, Armin Maghsoudlou, Ramak Roohipoor, Manuel Valdes-Navarro, Stacey Lee & C. Stephen Foster. (2016) Current Treatment Modalities of JIA-associated Uveitis and its Complications: Literature Review. Ocular Immunology and Inflammation 24:4, pages 431-439.
Read now
Francesco Semeraro, Andrea Russo, Elena Gambicorti, Sarah Duse, Francesco Morescalchi, Sara Vezzoli & Ciro Costagliola. (2015) Efficacy and vitreous levels of topical NSAIDs. Expert Opinion on Drug Delivery 12:11, pages 1767-1782.
Read now
Rishi Singh, Louis Alpern, Glenn J Jaffe, Robert P Lehmann, John Lim, Harvey J Reiser, Kenneth Sall, Thomas Walters & Dana Sager. (2012) Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology 6, pages 1259-1269.
Read now
KV Chalam, Vijay Khetpal & Chirag J Patel. (2012) Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate. Clinical Ophthalmology 6, pages 155-158.
Read now

Articles from other publishers (29)

Sücattin İlker Kocamış, Ali Altan Ertan Boz & İbrahim Özdemir. (2022) Systemic immune-inflammation index could be associated with pseudophakic cystoid macular edema after an uneventful phacoemulsification surgery in patients without risk factors. BMC Ophthalmology 22:1.
Crossref
Efrem D. Mandelcorn, Mohammed Al‐Falah, Lei Di Zhao, Peter Kertes, Robert Devenyi & Wai‐Ching Lam. (2021) A prospective randomized clinical trial comparing nepafenac, intravitreal triamcinolone and no adjuvant therapy for epiretinal membrane. Acta Ophthalmologica 100:1.
Crossref
Michał Orski & Maciej Gawęcki. (2021) Current Management Options in Irvine–Gass Syndrome: A Systemized Review. Journal of Clinical Medicine 10:19, pages 4375.
Crossref
Slawomir Jan Teper. (2021) Update on the Management of Uveitic Macular Edema. Journal of Clinical Medicine 10:18, pages 4133.
Crossref
. (2021) Multiple drugs. Reactions Weekly 1868:1, pages 285-285.
Crossref
Sashwanthi Mohan, Gajendra Chawla, Janani Surya & Rajiv Raman. (2021) Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema. Indian Journal of Ophthalmology 69:11, pages 3279.
Crossref
Danilo Aleo, Maria Grazia Saita, Fabiola Spitaleri, Claudia Sanfilippo & Angela Patti. (2020) Degradation profile of nepafenac in aqueous solution and structural characterization of a novel degradation product. Journal of Pharmaceutical and Biomedical Analysis 189, pages 113432.
Crossref
E.D. Sakalova. (2020) Modern approaches to treatment of postsurgical macular edema. Vestnik oftal'mologii 136:4, pages 289.
Crossref
Judith Rademacher, Denis Poddubnyy & Uwe Pleyer. (2020) Uveitis in spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease 12, pages 1759720X2095173.
Crossref
Anna Marmalidou & John B. Miller. 2020. Macular Disorders. Macular Disorders 101 108 .
Shahenda A El Gharbawy, Essam A Darwish, Khaled G Abu Eleinen & Moataz Hamed Osman. (2018) Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes. European Journal of Ophthalmology 29:4, pages 453-457.
Crossref
Horace Massa, Panagiotis Georgoudis & Georgios D Panos. (2019) Dexamethasone intravitreal implant (OZURDEX ® ) for macular edema secondary to noninfectious uveitis: a review of the literature . Therapeutic Delivery 10:6, pages 343-351.
Crossref
Tevfik Ogurel, Reyhan Ogurel, Fatma Ozkal, Yaşar Ölmez, Nurgül Örnek & Zafer Onaran. (2019) Evaluation effectiveness of 0.1% nepafenac on injection-related pain in patients undergoing intravitreal Ozurdex injection. Therapeutic Advances in Ophthalmology 11, pages 251584141986185.
Crossref
Tevfik Oğurel, Reyhan Oğurel, Zafer Onaran & Kemal Örnek. (2018) 0.1% Nepafenac reduces pain and increases patient comfort during cataract surgery. Contact Lens and Anterior Eye 41:5, pages 448-451.
Crossref
Chun-Ju Lin & Yi-Yu Tsai. (2018) USE OF AFLIBERCEPT FOR THE MANAGEMENT OF REFRACTORY PSEUDOPHAKIC MACULAR EDEMA IN IRVINE-GASS SYNDROME AND LITERATURE REVIEW. RETINAL Cases & Brief Reports 12:1, pages 59-62.
Crossref
Sean McCafferty, April Harris, Corin Kew, Tala Kassm, Lisa Lane, Jason Levine & Meisha Raven. (2017) Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo. BMC Ophthalmology 17:1.
Crossref
Reid Turner & Lucian V. Del Priore. 2017. Cystoid Macular Edema. Cystoid Macular Edema 77 89 .
Angela P. Bessette, Seenu M. Hariprasad & Rishi P. Singh. (2016) The Role of NSAIDs in the Management of Macular Edema. Ophthalmic Surgery, Lasers and Imaging Retina 47:8, pages 704-707.
Crossref
Raquel Goldhardt & Bradley Simon Rosen. (2016) Uveitic Macular Edema: Treatment Update. Current Ophthalmology Reports 4:1, pages 30-37.
Crossref
Richard J. Symes & Farzin Forooghian. (2016) Topical difluprednate monotherapy for uveitic macular edema. Canadian Journal of Ophthalmology 51:1, pages 47-49.
Crossref
Daniela Santos & Richard Hwang. 2016. Manual of Retinal Diseases. Manual of Retinal Diseases 415 420 .
Shiri Shulman, Gauti Jóhannesson, Einar Stefánsson, Anat Loewenstein, Amir Rosenblatt & Zohar Habot‐Wilner. (2015) Topical dexamethasone–cyclodextrin nanoparticle eye drops for non‐infectious Uveitic macular oedema and vitritis – a pilot study. Acta Ophthalmologica 93:5, pages 411-415.
Crossref
Suqin Guo, Shriji Patel, Ben Baumrind, Keegan Johnson, Daniel Levinsohn, Edward Marcus, Brad Tannen, Monique Roy, Neelakshi Bhagat & Marco Zarbin. (2015) Management of pseudophakic cystoid macular edema. Survey of Ophthalmology 60:2, pages 123-137.
Crossref
Sumru Onal, Ilknur Tugal-Tutkun, Piergiorgio Neri & Carl P Herbort. (2013) Optical coherence tomography imaging in uveitis. International Ophthalmology 34:2, pages 401-435.
Crossref
J T Toguri, C Lehmann, R B Laprairie, A M Szczesniak, J Zhou, E M Denovan-Wright & M E M Kelly. (2014) Anti-inflammatory effects of cannabinoid CB 2 receptor activation in endotoxin-induced uveitis . British Journal of Pharmacology 171:6, pages 1448-1461.
Crossref
Marina Borisovna Ro, Sergey Aleksandrovich Ignatyev, Igor Borisovich Alekseyev & Yelena Aleksandrovna Korchuganova. (2013) Successful treatment of the Irvine-Gass syndrome with Nevanac. Ophthalmology Reports 6:4, pages 69-72.
Crossref
Daniel F. Kiernan & Seenu M. Hariprasad. (2013) Controversies in the management of Irvine-Gass syndrome. Ophthalmic Surgery, Lasers and Imaging Retina 44:6, pages 522-527.
Crossref
Alaa E. Radwan, Cheryl A. Arcinue, Paul Yang, Pichaporn Artornsombudh, Esam M. Abu Al-Fadl & C. Stephen Foster. (2013) Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology 251:7, pages 1801-1806.
Crossref
David A. Goldman & William B. Trattler. (2010) Cataract Surgery and Diabetic Retinopathy. Ophthalmology 117:4, pages 850.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.